Solid Recommits to DMD Gene Therapy on Clinical Hold, as Stock Plunge Sparks Lawsuits – Genetic Engineering & Biotechnology News
|
Solid Recommits to DMD Gene Therapy on Clinical Hold, as Stock Plunge Sparks Lawsuits
Genetic Engineering & Biotechnology News Solid Biosciences restated its commitment to developing its lead candidate, the Duchenne muscular dystrophy (DMD) gene therapy SGT-001, despite the FDA’s full and partial clinical holds on a Phase I/II trial for the treatment. The FDA last month … |
|
Solid Recommits to DMD Gene Therapy on Clinical Hold, as Stock Plunge Sparks Lawsuits
Genetic Engineering & Biotechnology News Solid Biosciences restated its commitment to developing its lead candidate, the Duchenne muscular dystrophy (DMD) gene therapy SGT-001, despite the FDA’s full and partial clinical holds on a Phase I/II trial for the treatment. The FDA last month … |
Science Daily |
Gene therapy may help brain heal from stroke, other injuries
Science Daily The research examined spinal injuries but likely has implications for treating a number of brain conditions through gene therapy targeting astrocytes, said Dr. Mark Goldberg, Chairman of Neurology & Neurotherapeutics at UT Southwestern. “We’ve known … Astrocytes may help brain heal from stroke and spinal cord injuriesDrug Target Review |
Phys.Org |
From infection-dodging stem cells, new tactics for research on viral disease
Phys.Org It’s important that stem cells be protected from infection: some of them are starting material for babies, and others make up a crucial reservoir to build or rebuild body tissues as needed. An intruder that damaged or killed stem cells would be … Cryopreservation Equipment in Stem Cells Market Analysis and Forecast, 2025Healthcare Journal |
|
Indiana Polyclinic Debuts Groundbreaking Stem Cell Treatment Program
Markets Insider “We’re proud of our dedication to alleviating pain and suffering for our patients, and the new stem cell treatment program will provide us with even more ways to achieve those goals,” explained Dr. Dmitry Arbuck, MD, of the Indiana University School of … |
|
Indiana Polyclinic Debuts Groundbreaking Stem Cell Treatment Program
Benzinga “We’re proud of our dedication to alleviating pain and suffering for our patients, and the new stem cell treatment program will provide us with even more ways to achieve those goals,” explained Dr. Dmitry Arbuck, MD, of the Indiana University School of … |